Dyax, Genzyme agree to end drug collaboration
99180
THE REGION Cambridge biotech company Dyax Corp. has agreed to end its deal with Genzyme Corp. to codevelop a drug for the rare swelling disorder hereditary angioedema. The firms were jointly testing DX-88, a small protein considered Dyax's most important potential drug. Dyax said it will receive all the assets of the joint development deal and $17 million cash. Genzyme ...
301333
NEW YORK  - Genzyme Corp. announced  Wednesday that its drug Clolar has been approved by the U.S.  Food and Drug Administration (FDA) for the treatment of  children with difficult or relapsed acute lymphoblastic  leukemia (ALL).
494130
Genzyme Corp. announced Wednesday that its drug Clolar has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of children with difficult or relapsed acute lymphoblastic leukemia (ALL).
767331
Biopharma firm ends trials for a promising drug and offloads four commercial products.
327003
A lawsuit filed by New York State Attorney General Eliot Spitzer against GlaxoSmithKline over charges that the pharmaceutical company withheld information about the safety and effectiveness of Paxil has been settled.
402032
Mylan Laboratories Inc. (MYL.N: Quote, Profile, Research) , a maker of generic drugs, and King Pharmaceutical (KG.N: Quote, Profile, Research) on Wednesday reaffirmed their commitment
572919
Biotech titan Genzyme (Nasdaq: GENZ) has its roots in the treatment of rare genetic diseases and also has a significant presence in the treatment of renal diseases and providing diagnostic testing services.
39514
Alnylam Pharmaceuticals and Isis Pharmaceuticals, expect to announce Friday an equally owned joint venture to develop drugs that work by blocking so-called micro-RNAs.
702297
China and the United States will seal a cooperation pact next month to enhance drug safety and Beijing will launch a new sweep against the false advertising of medicines, China's drug watchdog said on Thursday.
273264
NEW YORK, Aug. 26 -- Drugmaker GlaxoSmithKline agreed Thursday to settle charges that it hid and misrepresented unfavorable data about the effectiveness and safety of its top-selling anti-depressant Paxil for children and adolescents, agreeing to post all clinical trial data on its drugs by the end of 2005.
743041
Drugmaker GlaxoSmithKline agreed Thursday to settle charges that it hid and misrepresented unfavorable data about the effectiveness and safety of its top-selling anti
476254
GlaxoSmithKline Plc, Europe&#39;s largest drugmaker, said it settled a lawsuit filed by New York Attorney General Eliot Spitzer, who accused the drugmaker last June of withholding safety data on the antidepressant Paxil.
638895
Indianapolis-based pharmaceutical firm says it will also close a research facility in North Carolina in effort to reduce drug prices.
594161
Genzyme announces positive study results with a recently acquired drug.
727578
GlaxoSmithKline PLC agreed Thursday to release information on its drug studies, including negative findings on the antidepressant Paxil, to settle a lawsuit in which New York&#39;s attorney general accused the company of fraud.
723247
GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research) has agreed to release all clinical studies of its drugs to settle a lawsuit that accused it of withholding negative information about the antidepressant Paxil, the New York
17093
ID Biomedical Corp. (IDB.TO: Quote, Profile, Research) (IDBE.O: Quote, Profile, Research) signed a 10-year US distribution deal for its Fluviral drug that could reap